Comments on: BMS and Novartis Provide Unrestricted Grants to Social Media Initiatives

By: Brad at Pharma

Brad at Pharma — Wed, 17 Dec 2008 15:54:36 +0000

Shwen,

Thanks for capturing this for us. It’s nice to hear about initiatives that my company is involved in… from outside my company … It’s good to see that the unrestricted grants are helping kick start the SocMedia environment.

Now, to track down the legal folks to see what kind of Adverse Event (AE) Reporting responsibility we have to assume with this… This seems to be the stumbling block in many of the discussions I’ve read. AEs. How do we report them? How do we track them? How do we maintain compliance with the FDA safety regulations? I know there are some tools out there, and now I’m wondering if we’re using them in this case… off to hunt people, now…

FULL DISCLOSURE : #iwork@novartis I work for Novartis Pharmaceuticals

By: Pharma Blog Review » Blog Archive » A new president, a look at the future, but the world goes on

Fri, 07 Nov 2008 07:52:03 +0000

[...] the Med 2.0 blog comes the news that Bristol-Myers Squibb and Novartist have provided unrestricted grants for social media initiatives, aimed at cancer patients. (Hat tip to Steve Woodruff of Impactiviti.) About the Bristol-Myers [...]

By: Pharma Marketing this week « Impactiviti blog

Pharma Marketing this week « Impactiviti blog — Thu, 06 Nov 2008 13:30:49 +0000

[...] and Novartis provide unrestricted grants for social media initiatives – full story here This is great news, and I think the most effective way pharma companies can start dabbling in [...]

By: shwen

shwen — Thu, 06 Nov 2008 03:12:36 +0000

Kairol,
Thanks for your comment – I totally agree with you, but as you know, Pharma has always been a slow adopter and cautious with where they dip their toes, especially if they feel like they cannot control the medium. However, it only makes sense to “fish Where the Fish Are” (like Chris Brogan’s eBook says).

By: shwen

shwen — Thu, 06 Nov 2008 03:09:30 +0000

Amy, You are most welcome – always glad to help out a good cause, especially one that uses social media! Will have to get Matt on a Med 2.0 podcast interview soon!

By: Kairol Rosenthal

Kairol Rosenthal — Tue, 04 Nov 2008 21:39:59 +0000

Cancer is stupid, but the folks at pharma are no dummies. Matthew Zachary’s audience, as well as the readers of my book (Everything Changes: The Insider’s Guide To Cancer In Their 20′s and 30′s), are ripe targets for online medical marketing. The Pew Internet and American Life Project shows that young adults more than any other age show benefit from seeking online health information. Pharma funds cancer conferences and cancer support groups; social networking for patients is a logical extension of these programs. Open the flood gates.